Chronic wounds affect approximately 6.5 million patients in the United States, and the number is increasing. Almost all chronic wounds contain biofilm, which is resistant to most antibiotics and many current antibacterial therapies. In the search for effective products to reduce biofilm, iodine dressings have outperformed other antibacterial dressings, including silver-based products, in several in vitro studies.

This illustrated and extensively referenced white paper, sponsored by Medline Industries, makers of IoPlex, discusses the value of iodine in biofilm management and describes the research demonstrating its effectiveness. IoPlex, a controlled-release iodine foam dressing, has potent in vitro activity against biofilms caused by several common pathogens. Although the clinical implications of these findings have yet to be determined, these results suggest that IoPlex may be effective for managing biofilm in wounds.

For wound care professionals, biofilm management presents an ongoing challenge. This white paper reports encouraging findings with a controlled-release iodine dressing in the quest to reduce biofilms in chronic wounds.

This white paper covers the following topics:

Sponsored by Medline Industries, Inc.